Expression of Ig-β (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion

Blood

Volumn 95, Issue 8, 2000, Pages 2725-2727

  Rassenti, Laura Z ^a   Kipps, Thomas J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD79A ANTIGEN; CD79B ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; UNCLASSIFIED DRUG;

ALLELE; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; IMMUNOGLOBULIN STRUCTURE; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 0034656395     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.8.2725     Document Type: Article

References (21)

1. Benschop RJ, Cambier JC. B cell development: signal transduction by antigen receptors and their surrogates. Curr Opin Immunol 1999;11: 143-151.
2. Thompson AA, Talley JA, Do HN, et al. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood. 1997;90: 1387-1394.
3. Papavasiliou F, Misulovin Z, Suh H, Nussenzweig MC. The role of Ig beta in precursor B cell transition and allelic exclusion. Science. 1995;268: 408-411.
4. Teh YM, Neuberger MS. The immunoglobulin (Ig) alpha and Ig beta cytoplasmic domains are independently sufficient to signal B cell maturation and activation in transgenic mice. J Exp Med. 1997;185:1753-1758.
5. Rassenti LZ, Kipps TJ. Lack of allelic exclusion in B cell chronic lymphocytic leukemia. J Exp Med. 1997;185:1435-1445.
6. Kipps TJ, Duffy SF. Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes. J Clin Invest. 1991;87:2087-2096.
7. Mason DY, Cordell JL, Brown MH, et al. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood. 1995;86: 1453-1459.
8. Okaraki M, Luo Y, Han T, Yoshida M, Seon BK. Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalized after binding to the cell surface antigen. Blood. 1993;81:84-94.
9. Nakamura T, Kubagawa H, Cooper MD. Heterogeneity of immunoglobulin-associated molecules on human B cells identified by monoclonal antibodies. Proc Natl Acad Sci U S A. 1992;89:3522-8526.
10. Hermanson GG, Eisenberg D, Kincade PW, Wall R. B29: a member of the immunoglobulin gene superfamily exclusively expressed on beta-lineage cells. Proc Natl Acad Sci U S A. 1988;85: 6890-6894.
11. Hashimoto S, Gregersen PK, Chiorazzi N. The human Ig-beta cDNA sequence, a homologue of murine B29, is identical in B cell and plasma cell lines producing all the human Ig isotypes. J Immunol. 1993;150:491-498.
12. Koyama M, Nakamura T, Higashihara M, et al. The novel variants of mb-1 and B29 transcripts generated by alternative mRNA splicing. Immunol Lett. 1995;47:151-156.
13. Alfarano A, Indraccolo S, Circosta P, et al. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia. Blood. 1999;93: 2327-2335.
14. Wood WJ Jr, Thompson AA, Korenberg J, et al. Isolation and chromosomal mapping of the human immunoglobulin-associated B29gene (IGB). Genomics. 1993;16:187-192.
15. Hashimoto S, Chiorazzi N, Gregersen PK. The complete sequence of the human CD79b (Ig beta/629) gene: identification of a conserved exon/intron organization, immunoglobulin-like regulatory regions, and allelic polymorphism. Immunogenetics. 1994;40:145-149.
16. Hashimoto S, Chiorazzi N, Gregersen PK. Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells. Mol Immunol. 1995;32:651-659.
17. Radovan E, Giachino C, Cella M, Valitutti S, Acuto O, Lanzavecchia A. Normal T lymphocytes can express two different T cell receptor beta chains: implications for the mechanism of allelic exclusion. J Exp Med. 1995;181:1587-1591.
18. Davodeau F, Peyrat MA, Romagne F, et al. Dual T cell receptor beta chain expression on human T lymphocytes. J Exp Med. 1995;181:1391-1398.
19. Balomenos D, Balderas RS, Mulvany KP, Kaye J, Kono DH, Theofilopoulos AN. Incomplete T cell receptor V beta allelic exclusion and dual V beta-expressing cells. J Immunol. 1995;155:3308-3312.
20. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V-H genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848-1854.
21. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840-1847.